Mechanisms regulating the binding activity of CD44 to hyaluronic acid
- PMID: 9634638
- DOI: 10.2741/a307
Mechanisms regulating the binding activity of CD44 to hyaluronic acid
Abstract
CD44 is a cell surface glycoprotein present on many cell types. Many CD44 isoforms have been identified. All CD44 isoforms utilize identical transmembrane and cytoplasmic domains. The hematopoietic form of CD44 (CD44H) is the major CD44 protein present on normal human lymphocytes and monocytes. One of the ligands for CD44 is hyaluronic acid (HA), a polymer consisting of repeat units of disaccharide; N-acetyl-D-glucosamine and N-acetyl-D-glucuronic acid. Since HA is present ubiquitously in extracellular matrix and in circulation, promiscuous binding of HA to CD44 may have undesirable affect. Similar to other adhesion molecules, binding of HA to cell surface CD44 requires regulation. In this review, we summarized our studies using a human lymphoma cell line, Jurkat. We found that binding of CD44+ Jurkat transfectants to HA requires cellular activation. Cellular activation induces the reorganization of the cytoskeleton proteins. Reorganization of cytoskeletal proteins results in clustering of CD44 on the cell surface. Clustering of CD44 on the cell surface is a prerequisite for the homodimerization of CD44. Our studies on Jurkat transfectants and results from other investigators suggest that interactions between CD44 and HA is a dynamic process and requires the participation of different cellular components; depending of the nature of the cell type and/or the nature of the activation signals.
Similar articles
-
A cysteine residue located in the transmembrane domain of CD44 is important in binding of CD44 to hyaluronic acid.J Exp Med. 1996 May 1;183(5):1987-94. doi: 10.1084/jem.183.5.1987. J Exp Med. 1996. PMID: 8642309 Free PMC article.
-
A requirement for the CD44 cytoplasmic domain for hyaluronan binding, pericellular matrix assembly, and receptor-mediated endocytosis in COS-7 cells.J Biol Chem. 2002 Mar 22;277(12):10531-8. doi: 10.1074/jbc.M108654200. Epub 2002 Jan 15. J Biol Chem. 2002. PMID: 11792695
-
Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity.J Cell Biol. 1996 Nov;135(4):1139-50. doi: 10.1083/jcb.135.4.1139. J Cell Biol. 1996. PMID: 8922392 Free PMC article.
-
CD44: structure, function, and association with the malignant process.Adv Cancer Res. 1997;71:241-319. doi: 10.1016/s0065-230x(08)60101-3. Adv Cancer Res. 1997. PMID: 9111868 Review.
-
CD44 and hyaluronan binding by human myeloid cells.Leuk Lymphoma. 1996 May;21(5-6):407-20, color plates following 528. doi: 10.3109/10428199609093438. Leuk Lymphoma. 1996. PMID: 9172805 Review.
Cited by
-
Dual Targeted Nanoparticles for the Codelivery of Doxorubicin and siRNA Cocktails to Overcome Ovarian Cancer Stem Cells.Int J Mol Sci. 2023 Jul 18;24(14):11575. doi: 10.3390/ijms241411575. Int J Mol Sci. 2023. PMID: 37511335 Free PMC article.
-
Induction of interactions between CD44 and hyaluronic acid by a short exposure of human T cells to diverse pro-inflammatory mediators.Immunology. 2000 Jul;100(3):345-51. doi: 10.1046/j.1365-2567.2000.00059.x. Immunology. 2000. PMID: 10929056 Free PMC article.
-
CD44 activation state regulated by the CD44v10 isoform determines breast cancer proliferation.Oncol Rep. 2021 Apr;45(4):7. doi: 10.3892/or.2021.7958. Epub 2021 Mar 2. Oncol Rep. 2021. PMID: 33649828 Free PMC article.
-
Immunotherapy as a Turning Point in the Treatment of Acute Myeloid Leukemia.Cancers (Basel). 2021 Dec 13;13(24):6246. doi: 10.3390/cancers13246246. Cancers (Basel). 2021. PMID: 34944865 Free PMC article. Review.
-
Targeted drug delivery utilizing protein-like molecular architecture.J Am Chem Soc. 2007 Apr 25;129(16):4961-72. doi: 10.1021/ja066929m. Epub 2007 Mar 31. J Am Chem Soc. 2007. PMID: 17397150 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous